BCLS Fund III Investments, LP - 30 Sep 2025 SCHEDULE 13G/A Report for DIANTHUS THERAPEUTICS, INC. Common Stock, $0.001 par value per share (DNTH)

Filing Manager
BCLS Fund III Investments, LP
Reporting Manager
BCLS Fund III Investments, LP
Security
DIANTHUS THERAPEUTICS, INC. Common Stock, $0.001 par value per share
Symbol
DNTH
Shares outstanding
42,448,129 shares
Disclosed Ownership
1,315,892 shares
Ownership
3.1%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 16:30:04 UTC
Date of event
30 Sep 2025
Previous filing
14 Aug 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"BCLS Fund III Investments, LP disclosed 3.1% ownership in DIANTHUS THERAPEUTICS, INC. Common Stock, $0.001 par value per share (DNTH) on 30 Sep 2025."

Quick Takeaways

  • BCLS Fund III Investments, LP filed SCHEDULE 13G/A for DIANTHUS THERAPEUTICS, INC. Common Stock, $0.001 par value per share (DNTH).
  • Disclosed ownership: 3.1%.
  • Date of event: 30 Sep 2025.

What Changed

  • Previous schedule filing date: 14 Aug 2025.
  • Current filing was accepted on 14 Nov 2025, 16:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BCLS Fund III Investments, LP 3.1% 1,315,892 0 1,315,892 /s/ Ricky Sun Ricky Sun, Partner of Bain Capital Life Sciences Investors, LLC

Sponsored